title: Gd-based macromolecules and nanoparticles as magnetic resonance contrast agents for molecular imaging.
abstract: As we move towards an era of personalized medicine, molecular imaging contrast agents are likely to see an increasing presence in routine clinical practice. Magnetic resonance (MR) imaging has garnered particular interest as a platform for molecular imaging applications due its ability to monitor anatomical changes concomitant with physiologic and molecular changes. One promising new direction in the development of MR contrast agents involves the labeling and/or loading of nanoparticles with gadolinium (Gd). These nanoplatforms are capable of carrying large payloads of Gd, thus providing the requisite sensitivity to detect molecular signatures within disease pathologies. In this review, we discuss some of the progress that has recently been made in the development of Gd-based macromolecules and nanoparticles and outline some of the physical and chemical properties that will be important to incorporate into the next generation of contrast agents, including high Gd chelate stability, high "relaxivity per particle" and "relaxivity density", and biodegradability.
authors: Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA.
authors: Ching-Hui
authors: CH
authors: Huang
authors: Andrew
authors: A
authors: Tsourkas
mesh_terms: D000818:Animals; D003287:Contrast Media / Q000737:chemistry; D005682:Gadolinium / Q000737:chemistry; D006801:Humans; D046911:Macromolecular Substances / Q000737:chemistry; D008279:Magnetic Resonance Imaging; D057054:Molecular Imaging; D053758:Nanoparticles / Q000737:chemistry; D009942:Organometallic Compounds / Q000737:chemistry
chemical_list: D003287:Contrast Media; D046911:Macromolecular Substances; D009942:Organometallic Compounds; D005682:Gadolinium